Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

DMAC - DiaMedica Therapeutics Inc. Financial... | Finranks

Home

/

DMAC

D

DiaMedica Therapeutics Inc. (DMAC)

NCM – Real Time Price. Currency in USD

6.79

-0.08 (-1.16%)

Market open: Aug 12, 2026, 11:08 AM EDT

6.77

-0.10 (-1.46%)

Previous after-hours: Aug 11, 2026, 7:43 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

0

0

Cost of goods sold

-43K

-39K

-30K

-25K

Gross Profit

-43K

-39K

-30K

-25K

Operating expenses (excl. COGS)

-34M

-27M

-21M

-14M

Operating Income

-34M

-27M

-21M

-14M

Non-operating income, total

2M

2M

2M

353K

Pretax income

-33M

-24M

-19M

-14M

Equity in earnings

0

0

0

0

Taxes

-28K

-30K

-43K

-28K

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-33M

-24M

-19M

-14M

Discontinued operations

0

0

0

0

Net income

-33M

-24M

-19M

-14M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

61M+32.4%

46M-14.4%

54M+57.5%

34M

Total current assets

61M

45M

54M

34M

Total non-current assets

742K

2M

485K

560K

Total liabilities

5M-6.5%

6M+81.3%

3M+20.8%

3M

Total current liabilities

5M

5M

3M

2M

Total non-current liabilities

128K

237K

317K

400K

Total equity

56M

41M

51M

32M

Total liabilities & shareholders' equities

61M

46M

54M

34M

Total debt

240K-29.4%

340K-15.0%

400K-14.7%

469K

Name

2025

2024

2023

2022

Cash from operating activities

-29M

-22M

-19M

-12M

Cash from investing activities

-2M

9M

-18M

12M

Cash from financing activities

44M

12M

37M

-6K

Free cash flow

-30M-33.5%

-22M-17.9%

-19M-61.8%

-12M